Immunotoxin complementation of HAART to deplete persisting HIV-infected cell reservoirs.
Berger
Edward A
EA
Laboratory of Viral Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, United States of America. edward_berger@nih.gov
Pastan
Ira
I
D000818:Animals; D023241:Antiretroviral Therapy, Highly Active; D003165:Complement System Proteins / Q000627:therapeutic use*; D006678:HIV / Q000472:pathogenicity*; D015658:HIV Infections / Q000188:drug therapy* / Q000276:immunology; D006801:Humans; D000922:Immunotoxins / Q000627:therapeutic use*; D014766:Viremia / Q000188:drug therapy* / Q000276:immunology
D000922:Immunotoxins; D003165:Complement System Proteins